The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
ZEOX · Healthcare · Shallow moat
Doesn't clear the bar
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
| Measure | ZEOX | CRMD | SRTS | ESTA |
|---|---|---|---|---|
| Moat Score (0–100) | 42 (highest) | 42 (highest) | 42 (highest) | 42 (highest) |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 27 | 78 (highest) | 31 | 65 |
| Pricing power | 70 | 11 | 90 | 94 (highest) |
| Returns on capital | — | 4 | 11 (highest) | 0 |
| Balance-sheet safety | 28 | 73 (highest) | 55 | 28 |
| Capital allocation | 44 (highest) | 44 (highest) | 24 | 24 |
| No price data | No price data | 2% below value if growth stopped today | No price data | |
| Market cap | $11.1M | $624M | $49.9M | $2.7B |
| Moat tier | Shallow moat | Shallow moat | Shallow moat | Shallow moat |
| Filing date | FY2025 | FY2025 | FY2025 | FY2025 |